Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation

Kocyigit, DUYGU; Gurses, Kadri; Yalcin, Muhammed; CANPINAR, HANDE; CANPOLAT, UĞUR; EVRANOS, BANU; YORGUN, HİKMET; ÖZER, NECLA; Guc, DİCLE; AYTEMİR, KUDRET

doi:10.1002/jcla.22120

Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation

Kocyigit D., Gurses K. M., Yalcin M. U., CANPINAR H., CANPOLAT U., EVRANOS B., ...Daha Fazla

JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.31, sa.6, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 31 Sayı: 6
Basım Tarihi: 2017
Doi Numarası: 10.1002/jcla.22120
Dergi Adı: JOURNAL OF CLINICAL LABORATORY ANALYSIS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: atrial fibrillation, galectin-3, left atrial appendage flow velocity, transesophageal echocardiography, C-REACTIVE PROTEIN, SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST, PLATELET ACTIVATION, PROTHROMBOTIC STATE, STROKE PREVENTION, RISK-FACTOR, SPAF-III, THROMBOEMBOLISM, ASSOCIATION, QUANTIFICATION
Hacettepe Üniversitesi Adresli: Evet

Özet

BackgroundLeft atrial appendage flow velocity (LAAFV) and presence of spontaneous echo contrast (SEC) have been reported to be predictors of thromboembolism in atrial fibrillation (AF) patients. Galectin-3 is a biomarker reflecting pro-inflammatory status, whose role in AF has recently drawn attention, particularly in persistent AF population.